Case Details
- Citation: [2016] SGHC 21
- Case Title: Hii Chii Kok v Ooi Peng Jin London Lucien and another
- Court: High Court of the Republic of Singapore
- Date of Decision: 22 February 2016
- Case Number: Suit No 806 of 2012
- Judge: Chan Seng Onn J
- Coram: Chan Seng Onn J
- Plaintiff/Applicant: Hii Chii Kok
- Defendants/Respondents: (1) Ooi Peng Jin London Lucien (2) National Cancer Centre of Singapore Pte Ltd (“NCCS”)
- Legal Areas: Tort – Negligence – Breach of duty; Tort – Negligence – Causation
- Outcome on Appeal: Appeal dismissed by the Court of Appeal on 12 May 2017 (Civil Appeal No 33 of 2016); see [2017] SGCA 38
- Counsel for Plaintiff: Palaniappan Sundararaj and Lim Min (Straits Law Practice LLC)
- Counsel for First Defendant: Edwin Tong SC, Mak Wei Munn, Tham Hsu Hsien, Christine Tee and Hoh Jian Yong (Allen & Gledhill LLP)
- Counsel for Second Defendant: Kuah Boon Theng, Felicia Chain, Gerald Soo and Karen Yong (Legal Clinic LLC)
- Judgment Length: 64 pages; 35,339 words
- Statutes Referenced: None specified in the provided extract
Summary
This High Court decision concerns a claim in medical negligence arising from the diagnosis and management of a pancreatic condition. The plaintiff, Dato’ Seri Hii Chii Kok, was assessed by a multidisciplinary team at the National Cancer Centre of Singapore (NCCS) as possibly having pancreatic neuroendocrine tumours (“PNETs”) at two sites in his pancreas: the pancreatic body (“PB lesion”) and the uncinate process (“PU lesion”). The team also considered a differential diagnosis of pancreatic polypeptide hyperplasia (“hyperplasia”), a rare but less serious condition. The plaintiff proceeded with a Whipple procedure and related pancreatic surgery after being informed of the competing diagnoses and management options.
Post-operative histopathology ultimately revealed that the plaintiff did not have PNETs; instead, he had hyperplasia. He then sued the surgeon, Prof Ooi, and NCCS, alleging negligence in (i) the diagnosis and (ii) the advice and post-operative management. The court held that, applying Singapore’s established medical negligence framework, the defendants were not negligent. Even if the court were to apply the more patient-centric “informed consent” approach associated with English law developments, the defendants’ conduct would still not amount to negligence on the facts.
What Were the Facts of This Case?
The plaintiff is a Malaysian businessman and founder/executive chairman of a conglomerate with diversified business interests, and he was the controlling shareholder of a private education provider in Malaysia. He held a law degree and had worked as an English language journalist. His medical history included consultations in Malaysia for issues involving his lungs, thyroid, and prostate, and he had undergone surgery for hyperthyroidism in 2000. In 2003, nodules were discovered in his lungs.
In or around November 2006, the plaintiff experienced pain in his left shoulder and underwent a chest x-ray at Sime Darby Medical Centre (SDMC) in Selangor, Malaysia. The x-ray showed an oval-shaped solid 12mm nodule in the lateral segment of the right middle lobe. The lung nodule grew to 18mm by June 2010. A computed tomography-guided biopsy performed on 8 July 2010 identified the lung nodule as a neuroendocrine tumour of low grade malignancy (“lung NET”).
On 13 July 2010, the plaintiff consulted Dr Foo Yoke Ching, a medical oncologist at SDMC, regarding treatment of the lung NET. Dr Foo YC diagnosed the plaintiff with neuroendocrine carcinoma of the right lung and considered it advisable for the plaintiff to undergo a “radioisotope Gallium scan” in Singapore to further investigate his condition. She referred the plaintiff to Dr Koo, a medical oncologist at NCCS, and indicated that the plaintiff was keen to have surgery in Singapore.
On 19 July 2010, the plaintiff underwent a positron emission tomography (PET) scan using Gallium-68 DOTATATE (the “Gallium scan”) combined with a CT scan (together, the “Gallium PET/CT”). The scan showed very minimal tracer uptake in the right lung nodule, but it revealed focal areas of increased tracer uptake in the pancreatic uncinate process (SUVmax 23.0) and in the pancreatic body (SUVmax 13.2), with no definite corresponding mass or soft tissue thickening. The scan also showed mildly increased tracer uptake in the thyroid parenchyma, which could be secondary to hyperplasia. The plaintiff was advised that the pancreatic uptake could suggest PNETs, but because no definite mass was seen, further imaging was recommended.
What Were the Key Legal Issues?
The principal legal issues were whether the defendants breached their duty of care in relation to (1) the diagnosis of the plaintiff’s pancreatic lesions and (2) the advice and post-operative management provided to him. The claim was framed in negligence, requiring the plaintiff to establish both breach of duty and causation: that the defendants fell below the standard of care and that this failure caused the plaintiff’s loss.
A further, more doctrinal issue concerned the appropriate legal test for assessing medical negligence in Singapore. The court addressed whether the “Bolam–Bolitho” test—derived from English law and adopted in Singapore—should govern not only diagnosis and treatment, but also the adequacy of medical advice, particularly advice concerning material risks and alternative treatment options. The plaintiff’s case implicitly invited the court to consider whether the doctrine of informed consent should apply instead of Bolam–Bolitho for advice-related allegations.
How Did the Court Analyse the Issues?
Chan Seng Onn J began by setting out the governing law of medical negligence in Singapore. The court noted that Singapore follows the Court of Appeal’s decision in Khoo James v Gunapathy, which in turn applies the Bolam–Bolitho framework. Under this approach, the question is whether the doctor’s conduct accords with the standard of a responsible body of medical opinion, subject to the Bolitho qualification that the medical opinion relied upon must be logically defensible.
The court then addressed the plaintiff’s attempt to shift the framework from Bolam–Bolitho to an informed consent model. The judge observed that, in earlier High Court decisions, arguments had been raised that informed consent should apply to advice about material risks and alternatives rather than Bolam–Bolitho. However, those decisions also recognised that the High Court is bound by Khoo James to apply Bolam–Bolitho in relation to medical advice. The judge therefore proceeded on the basis that Bolam–Bolitho governed the negligence analysis in this case.
Importantly, the court also engaged with developments in English law. It explained that English law has moved towards a patient-centric informed consent doctrine, associated with Montgomery v Lanarkshire Health Board. The court acknowledged the policy rationale for this shift away from medical paternalism. Nevertheless, the judge emphasised that, as a matter of binding authority, Singapore’s current position remained anchored in Bolam–Bolitho for medical advice. The court nevertheless stated that even if Montgomery-style analysis were applied, the defendants’ conduct would still not amount to negligence on the facts.
On the merits, the court accepted that the multidisciplinary team had identified both a clinical diagnosis (PNETs) and a differential diagnosis (hyperplasia). The judge highlighted that the consensus among expert witnesses was that the most definitive way to distinguish PNETs from hyperplasia was post-operative histopathology. The court found no evidence that any diagnostic tool or investigative procedure could reliably differentiate between these two conditions pre-operatively. This factual finding was central: it meant that the defendants were not confronted with a situation where the correct diagnosis could have been known with certainty before surgery.
The court further examined the defendants’ decision-making process. The NCCS tumour board model involved a multidisciplinary team with relevant sub-specialty skills. The plaintiff’s case was discussed to reach a consensus on diagnosis and treatment options. The court treated this as relevant to whether the defendants acted in accordance with responsible medical practice. The defendants were alive to the possibility of hyperplasia, and the plaintiff was informed of both diagnoses and the options flowing from them, including the option of waiting for six months versus proceeding with surgical resection of the pancreatic lesions.
With respect to advice and risk disclosure, the court’s reasoning was tied to the nature of the uncertainty inherent in the pre-operative diagnostic picture. Because the definitive distinction between PNETs and hyperplasia required histopathology, the risk that surgery would reveal hyperplasia rather than PNETs was not a foreseeable “avoidable” error but rather an outcome consistent with the limitations of available pre-operative diagnostics. The court found that the plaintiff had been informed of the diagnoses and options, and that the decision to proceed with “aggressive treatment” was made by the plaintiff after considering the risks and alternatives.
Finally, the court addressed post-operative management. The judge concluded that Prof Ooi was not negligent in the post-operative management of the plaintiff. While the extract provided does not reproduce the full post-operative narrative, the court’s overall conclusion indicates that the plaintiff’s complaint did not establish that the defendants deviated from the standard of care in monitoring, interpreting post-operative findings, or managing the clinical course after surgery.
What Was the Outcome?
The High Court dismissed the plaintiff’s claim. Chan Seng Onn J found that the defendants were not negligent in reaching the diagnoses and in rendering advice to the plaintiff. The court also held that Prof Ooi was not negligent in the post-operative management of the plaintiff.
Practically, the decision affirms that where pre-operative diagnostic uncertainty exists and where the medical team identifies and communicates the relevant differential diagnoses and treatment options, a later “wrong” histopathological outcome does not, by itself, establish negligence. The plaintiff’s appeal was subsequently dismissed by the Court of Appeal on 12 May 2017 (Civil Appeal No 33 of 2016), as noted in the LawNet editorial note.
Why Does This Case Matter?
Hii Chii Kok v Ooi Peng Jin London Lucien is significant for medical negligence doctrine in Singapore because it reiterates the continued application of the Bolam–Bolitho test to medical advice, consistent with binding Court of Appeal authority. The judgment is also useful for practitioners because it shows how the High Court approaches arguments for adopting an informed consent framework in the context of advice about risks and alternatives. Even though the court discussed Montgomery and the broader international trend, it confirmed that Singapore’s legal position remains governed by Khoo James unless and until the Court of Appeal changes the framework.
From a litigation perspective, the case underscores the importance of expert consensus and the evidential role of medical limitations. Where experts agree that no pre-operative diagnostic tool can definitively distinguish between two conditions, courts are less likely to infer breach of duty from the mere fact that histopathology later revealed the less serious diagnosis. This is particularly relevant in complex oncology and pathology-adjacent cases where imaging findings can be suggestive but not conclusive.
For clinicians and healthcare institutions, the decision highlights the value of multidisciplinary tumour board processes and documented communication of options. The court’s emphasis on the plaintiff being informed of both the clinical and differential diagnoses, as well as the choice between waiting and surgery, provides a practical template for risk communication and shared decision-making—at least within the Bolam–Bolitho framework currently applicable in Singapore.
Legislation Referenced
- No specific statute is identified in the provided judgment extract.
Cases Cited
- [2002] 1 SLR(R) 1024 — Khoo James and another v Gunapathy d/o Muniandy and another appeal
- [1957] 1 WLR 582 — Bolam v Friern Hospital Management Committee
- [1998] AC 232 — Bolitho v City and Hackney Health Authority
- [2010] 1 SLR 428 — Surender Singh s/o Jagdish Singh and another (administrators of the estate of Narindar Kaur d/o Sarwan Singh, deceased) v Li Man Kay and others
- [2011] SGHC 193 — D’Conceicao Jeanie Doris (administratrix of the estate of Milakov Steven, deceased) v Tong Ming Chuan
- [2013] 2 SLR 18 — Tong Seok May Joanne v Yau Hok Man Gordon
- [2015] AC 1430 — Montgomery v Lanarkshire Health Board (General Medical Council intervening)
- [2016] SGHC 21 — Hii Chii Kok v Ooi Peng Jin London Lucien and another
- [2017] SGCA 38 — Hii Chii Kok v Ooi Peng Jin London Lucien and another (Court of Appeal dismissal of appeal)
Source Documents
This article analyses [2016] SGHC 21 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.